ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached the Investor Presentation for the quarter ended 30th June, 202304-08-2023
04-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached the Press Release for the Quarter ended 30.06.202304-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Unaudited Financial Results For The Quarter Ended 30.06.2023
Please find enclosed the Unaudited Financial Results for the qtr ended 30th June, 202304-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Board Meeting Outcome for Outcome Of Board Meeting
Approved the Unaudited Financial Results for the quarter ended 30th June, 2023. Designated Dr. Onkar Swami Sr. Vice President - Medical Service, as Senior Management Personnel of the Company w.e.f. 5th August, 2023.04-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 29th July, 2023 received from Lijnk Intime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).29-07-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 24th July, 2023, received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).24-07-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Clarification On Movement In Volume
With reference to the captioned matter and your notification disseminated on BSE''s website under the company''s corporate Announcement page, we would like to state that the Company has made all the necessary disclosure pursuant to the provisions of the SEBI LODR and has not withheld any material information/ event that in our opinion would have bearing on the volume of the security of the Company.22-07-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith intimation dated 21st July, 2023 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s) for the purpose of claiming those shares from the Investors Education and Protection Fund(IEPF).21-07-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The exchange is hereby informed that the Company will hold Post Results Conference Call on Friday, 4th August, 2023 as per the enclosed details.21-07-2023